Published in
Elsevier, Lancet Gastroenterology and Hepatology, 2(5), p. 152-166, 2020
DOI: 10.1016/s2468-1253(19)30346-2
Links
Tools
Safety, pharmacokinetics, and antiviral effects of ABI-H0731, a hepatitis B virus core inhibitor: a randomised, placebo-controlled phase 1 trial
Journal article published in 2020 by
Man-Fung Yuen,
Kosh Agarwal 
,
Edward J. Gane,
Christian Schwabe,
Sang Hoon Ahn,
Dong Joon Kim,
Young-Suk Lim,
Wendy Cheng,
William Sievert,
Kumar Visvanathan,
Eric Ruby,
Sandy Liaw,
Ran Yan,
Qi Huang,
Richard Colonno
and other authors.
,
Edward J. Gane,
Christian Schwabe,
Sang Hoon Ahn,
Dong Joon Kim,
Young-Suk Lim,
Wendy Cheng,
William Sievert,
Kumar Visvanathan,
Eric Ruby,
Sandy Liaw,
Ran Yan,
Qi Huang,
Richard Colonno
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 